US2008269344A1PendingUtilityA1
Beta2-Adrenergic Receptor Agonists
Individually held — no corporate assignee on recordPriority: Dec 8, 1999Filed: Jun 25, 2008Published: Oct 30, 2008
Est. expiryDec 8, 2019(expired)· nominal 20-yr term from priority
A61P 43/00A61P 3/10A61P 3/04A61P 25/00A61P 11/08A61P 1/00A61P 11/06A61P 15/06A61P 11/00A61K 31/4706C07C 215/60A61K 45/06A61K 31/404A61K 31/4164C07C 233/43A61K 31/137A61K 31/167C40B 40/00C07C 215/68A61K 31/403
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are multibinding compounds which are β2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also useful in the treatment of nervous system injury and premature labor.
Claims
exact text as granted — not AI-modified1 - 53 . (canceled)
54 . A method of treating asthma or chronic obstructive pulmonary disease in a mammal, the method comprising administering to the mammal a pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a pharmaceutically-acceptable salt of a compound of the formula:
55 . The method of claim 54 wherein the method comprises administering the pharmaceutical composition to the mammal by inhalation.
56 . The method of claim 54 wherein the method further comprises administering a steroidal anti-inflammatory agent to the mammal.
57 . The method of claim 54 wherein the mammal is a human.
58 . A method of treating asthma or chronic obstructive pulmonary disease in a mammal, the method comprising administering to the mammal a pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a compound of the formula:
59 . The method of claim 58 wherein the method comprises administering the pharmaceutical composition to the mammal by inhalation.
60 . The method of claim 58 wherein the method further comprises administering a steroidal anti-inflammatory agent to the mammal.
61 . The method of claim 58 wherein the mammal is a human.
62 . A method of treating asthma or chronic obstructive pulmonary disease in a mammal, the method comprising administering to the mammal a pharmaceutically-acceptable salt of a compound of the formula:
63 . The method of claim 62 wherein the method comprises administering the pharmaceutically-acceptable salt of the compound to the mammal by inhalation.
64 . The method of claim 62 wherein the method further comprises administering a steroidal anti-inflammatory agent to the mammal.
65 . The method of claim 62 wherein the mammal is a human.
66 . A method of agonizing a β 2 adrenergic receptor in a mammal, the method comprising administering to the mammal a compound of the formula:
67 . The method of claim 66 wherein the mammal is a human.Join the waitlist — get patent alerts
Track US2008269344A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.